Literature DB >> 32781858

Differential lung inflammation and injury with tobacco smoke exposure in Wistar Kyoto and spontaneously hypertensive rats.

Alexa K Pham1, Ching-Wen Wu1, Xing Qiu2, Jingyi Xu2, Suzette Smiley-Jewell1, Dale Uyeminami1, Priya Upadhyay1, Dewei Zhao2, Kent E Pinkerton1.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide and has been associated with periods of intense lung inflammation. The objective of this study was to characterize whether similar rat strains, possessing different genetic predispositions, might play a role in exacerbating the pathophysiology of COPD-like cellular and structural changes with progressive 12-week exposure to tobacco smoke (TS). Normotensive Wistar Kyoto (WKY) and spontaneously hypertensive (SH) rats were compared.
MATERIALS AND METHODS: WKY and SH rats were exposed to filtered air or to tobacco smoke at a particulate concentration of 80 mg/m3 for 4, 8, or 12 weeks. Necropsy was performed 24 h after the last exposure to obtain cells by bronchoalveolar lavage for total cell and differential counts. Scoring of lung tissues and immunohistochemical staining for M1 (pro-inflammatory) and M2 (anti-inflammatory) macrophages were performed on paraffin-embedded lung sections. RESULTS AND DISCUSSION: With progressive exposure, TS-exposed SH rats demonstrated significant airspace enlargement, mucin production, and lung inflammation compared to their FA control and TS-matched WKY rats. Moreover, SH rats also demonstrated increased expression of the M1 marker in alveolar macrophages compared to FA control, as well as the M2 marker compared to controls and TS-exposed WKY rats.
CONCLUSION: The progressive tobacco smoke exposure contributes to persistent lung injury and inflammation that can be significantly enhanced by rat strain susceptibility in the genesis of COPD.

Entities:  

Keywords:  Tobacco smoke; Wistar Kyoto rats; chronic obstructive pulmonary disease; macrophage; spontaneously hypertensive rats

Mesh:

Substances:

Year:  2020        PMID: 32781858      PMCID: PMC8034838          DOI: 10.1080/08958378.2020.1805052

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  49 in total

1.  Is systemic inflammation responsible for pulmonary hypertension in COPD?

Authors:  Don D Sin; S F Paul Man
Journal:  Chest       Date:  2006-08       Impact factor: 9.410

2.  Smoking and COPD: What really are the risks?

Authors:  S Marsh; S Aldington; P Shirtcliffe; M Weatherall; R Beasley
Journal:  Eur Respir J       Date:  2006-10       Impact factor: 16.671

3.  Long-Term Sequelae of Smoking and Cessation in Spontaneously Hypertensive Rats.

Authors:  Ching-Wen Wu; Tammy Yau; Ciara C Fulgar; Savannah M Mack; Alina M Revilla; Nicholas J Kenyon; Kent E Pinkerton
Journal:  Toxicol Pathol       Date:  2019-12-24       Impact factor: 1.902

4.  Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine.

Authors:  Sandra Hodge; Geoffrey Matthews; Violet Mukaro; Jessica Ahern; Aruna Shivam; Greg Hodge; Mark Holmes; Hubertus Jersmann; Paul N Reynolds
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-01       Impact factor: 6.914

Review 5.  Treating Hypertension in Chronic Obstructive Pulmonary Disease.

Authors:  Shannon W Finks; Mark J Rumbak; Timothy H Self
Journal:  N Engl J Med       Date:  2020-01-23       Impact factor: 91.245

6.  Early life exposure to environmental tobacco smoke alters immune response to asbestos via a shift in inflammatory phenotype resulting in increased disease development.

Authors:  Traci Ann Brown; Andrij Holian; Kent E Pinkerton; Joong Won Lee; Yoon Hee Cho
Journal:  Inhal Toxicol       Date:  2016-05-03       Impact factor: 2.724

7.  Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat.

Authors:  Marco H Santamaria; Angela Y Chen; Jason Chow; Diana C Muñoz; Geert W Schmid-Schönbein
Journal:  Microvasc Res       Date:  2014-08-27       Impact factor: 3.514

8.  Interaction between smoking and genetic factors in the development of chronic bronchitis.

Authors:  Jenny Hallberg; Annica Dominicus; Ulrika K Eriksson; Maria Gerhardsson de Verdier; Nancy L Pedersen; Magnus Dahlbäck; Ulf Nihlén; Tim Higenbottam; Magnus Svartengren
Journal:  Am J Respir Crit Care Med       Date:  2007-11-29       Impact factor: 21.405

9.  Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis.

Authors:  E Gamble; D C Grootendorst; K Hattotuwa; T O'Shaughnessy; F S F Ram; Y Qiu; J Zhu; A M Vignola; C Kroegel; F Morell; I D Pavord; K F Rabe; P K Jeffery; N C Barnes
Journal:  Eur Respir J       Date:  2007-05-15       Impact factor: 16.671

10.  Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease.

Authors:  Yoichiro Kaku; Haruki Imaoka; Yoshitaka Morimatsu; Yoshihiro Komohara; Koji Ohnishi; Hanako Oda; Shinichi Takenaka; Masanobu Matsuoka; Tomotaka Kawayama; Motohiro Takeya; Tomoaki Hoshino
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.